34th Annual Winter Meeting: Midwest Society of Colon and Rectal Surgeons

Reservations

Book accommodations by calling 800-548-4486 or clicking here to visit the booking site.

Summit 1 Bedroom	$1,029
Summit 1 King	$669
Summit 2 Queen	$649
Summit Queen Studio	$599

 

Description 

Designed For

Jointly Provided By 

Times listed are in Mountain Time (MT).

Thursday, March 12, 2026

3:30 p.m.
Registration and Refreshments

4 p.m.
Operating on the Obese
Forrest Johnston, MD, FACS, FASCRS

• •           Recognize risk factors for increased risk of operative morbidity based on obesity
  •       Understand the increased risk and complexity of operating on the obese patients to  add to routine preoperative discussion
  •       Change or modify surgical technique or approach to best fit patient body habitus. 

      4:25 p.m.
Anal Cancer
Jennifer Leinicke, MD, MPHS, FACS, FASCRS

4:50 p.m.
Colorectal Medicine
Ben Martin, MD

• •          Recognize common gastrointestinal and anorectal conditions that colorectal surgeons frequently manage medically
  •      Review the evidence-based medical management strategies for non-surgical colorectal conditions
  •      Discuss practical approaches colorectal surgeons can use to manage these conditions effectively and when to coordinate with other specialties

5:15 p.m.
Innovations in Robotics for Colon and Rectal Surgeons
Jamie Cannon, MD

• •           Recognize the benefits and limitations of robotic colorectal cancer surgery
  •      Be familiar with intracorporeal anastomotic techniques
  •      Identify transanal approaches for varying pathology

5:40 p.m.
Is Your APP Stealing Your RVUs?
Emily Connor, MSN, APRN, AGCNS-BC, AGPCNP-BC

• • Identify the impact of APPs on clinic volume of the surgeon.
  • Identify the impact of APPs on OR cases of the surgeon.
  • Openly discuss the topic of the effect of APPs on surgeon RVUs in your own practice.

6:05 p.m.
Evaluation and Adjournment

6:30 p.m.
Welcome Reception and Pizza Party

---

Friday, March 13, 2026

6:15 a.m.
Registration and Continental Breakfast

6:45 a.m.
Immunotherapy in Colon Cancer: Current Evidence and Future Directions
Jennifer Paruch, MD, MS, FACS, FASCRS

• •           Describe the current role of immunotherapy in colon cancer, including approved indications and key clinical trial data.
  • Explain the biological rationale for immunotherapy in colon cancer, with emphasis on predictive biomarkers such as MSI/MMR status and mechanisms of resistance.
  • Evaluate emerging immunotherapeutic strategies and combination approaches and their potential impact on future clinical practice.

 7:10 a.m.
More RVUs in Less Time: What You Need to Know
Peter Marcello, MD, FACS, FASCRS

• •            Review how RVUs are developed
  •       Discuss differences in RVU for open and lap procedures
  •       Review RVUs for endoscopic procedures

7:35 a.m.
HPV Vaccine and Anal Dysplasia: An Update
J. Ryan Williams, MD

• • Understand the role of HPV in dysplasia and transformation to anal cancer
  • Describe the indications for anal cancer screening
  • Discuss the role of vaccination in prevention and possible treatment of anal dysplasia

8 a.m.
Balancing Administrative, Clinical and Research Activities for the Colon and Rectal Surgeon
Larry Sands, MD, MBA

• •       To understand the rigors of academic medicine in 2026
  •       To discuss what leadership looks like in academic medicine
  •       To discuss methods of balance in a busy career

8:25 a.m.
Honoring a Visionary in Peritoneal Surface Malignancy: Oncologic Outcomes and Clinical Lessons Learned from the Legacy of Dr. Floriano Marchetti
Austin Dosch, MD

• •       Describe the clinical characteristics, treatment strategies, and outcomes of peritoneal surface malignancy patients treated with CRS/HIPEC within University of Miami database, highlighting key predictors of survival and recurrence.
  •      Evaluate patient selection factors and operative considerations that influence outcomes in CRS/HIPEC.
  •      Discuss how insights from this historical HIPEC experience can guide contemporary management of peritoneal metastases, including current indications, limitations, and opportunities for future clinical and translational research.

9 a.m.
Evaluation and Adjournment

Reconvene

4 p.m.
Tracking Surgical Waste
Alice Lee, MD

4:25 p.m.
Management of Colorectal Cancer in Lynch Syndrome
Meghana Kashyap, MD

• •       Identify patients at risk for Lynch syndrome using clinical features, universal tumor testing (MSI/IHC), and appropriate indications for germline evaluation.
  •      Incorporate gene-specific cancer risk into surgical decision-making, including selecting between segmental and extended colectomy in patients with Lynch-associated colorectal cancer.
  •      Develop evidence-based surveillance and multidisciplinary management plans for patients with Lynch syndrome, including postoperative colonoscopic surveillance and coordination of extracolonic cancer screening. 

4:50 p.m.
What Can AI do for You?  How to Integrate AI into Colorectal Practice
Jonathan Abelson, MD

5:15 p.m.
Rectal Prolapse
Pamela Burgess, MD

5:40 p.m.
Management of Acute Large Bowel Obstruction
Michael Watson, MD

• •       Describe the evidence-based evaluation and management of patients with acute large bowel  obstruction
  •      Identify the correct surgical treatment of patients with acute malignant large bowel obstruction based on individualized patient factors
  •      Describe advanced techniques used for managing acute large bowel obstruction including colon stenting, on-table colon lavage, and extraperitoneal colostomy creation

6:30 p.m.
Evaluation and Adjournment

---

Saturday, March 14, 2026

6:15 a.m.
Registration and Continental Breakfast

6:45 a.m.
Management of EEA Anastomotic Complications
Jonathan Bliggenstorfer, MD

7:10 a.m.
Medical Management of IBD: From Biologics to Small Molecules to Immunomodulators
Randall Pellish, MD

7:35 a.m.
Deep Endometriosis and the Colon and Rectal Surgeon
Dave Bennett, MD

8 a.m.
Jorge Marcet, MD

8:25 a.m.
Extended Mesorectal Excision for Rectal Cancer
Avanish Saklani, MBBS

9 a.m.
Evaluation and Adjournment

Reconvene

4 p.m.
Robot Single Port for Colorectal Abdominal and Transrectal TAMIS Application
Joseph Corallo, MD

4:25 p.m.
The Role of Circulating Tumor DNA (ctDNA) in Colorectal Cancer Surveilance
Brian Kann, MD

5 p.m.
Locally Advanced Rectal Cancer
Heidi Bahna, MD

5:25 p.m.
Interesting Cases

6:30 p.m.
Evaluation and Adjournment